MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹5,664 Cr | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹5,664 Cr |
| Mar2024 | ₹2,120 Cr |
| Mar2023 | ₹1,863 Cr |
| Mar2022 | ₹2,623 Cr |
| Mar2021 | ₹1,353 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,664 Cr | 167.18 | |
| Mar2024 | ₹2,120 Cr | 13.77 | |
| Mar2023 | ₹1,863 Cr | -28.98 | |
| Mar2022 | ₹2,623 Cr | 93.84 | |
| Mar2021 | ₹1,353 Cr | - | |
Compare Total Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹90,256.7 Cr | -2.7% | 4.6% | -2.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,628.0 Cr | 3.5% | 5.6% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,975.0 Cr | -1.3% | 4.5% | 16.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,804.0 Cr | -0.7% | 6.9% | 47.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,829.0 Cr | 1.3% | 5.1% | 17.5% | Stock Analytics | |
| CIPLA | ₹106,768.0 Cr | -1.9% | -0.3% | -6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -2.7% |
4.6% |
-2.8% |
| SENSEX | -4.1% |
-5.8% |
5.8% |
You may also like the below Video Courses